GenoLogics Raises $8M in Private Financing; Illumina Invests | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GenoLogics today said that it has raised $8 million in a private round of financing led by Illumina, a new investor in the firm.

The Victoria, British Columbia-based bioinformatics firm said that the funds would be used to accelerate product development for future clinical applications and new desktop sequencing systems and to expand its sales and marketing functions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.